Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report

BACKGROUND: Palbociclib is a selective well-tolerated antineoplastic drug used in the treatment of advanced HER2-negative, estrogen-receptor positive breast cancer that has shown significant improvement in progression-free survival. We present a patient that developed severe rhabdomyolysis with tetr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nersesjan, Vardan, Hansen, Klaus, Krag, Thomas, Duno, Morten, Jeppesen, Tina D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806583/
https://www.ncbi.nlm.nih.gov/pubmed/31640597
http://dx.doi.org/10.1186/s12883-019-1490-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806583/
https://www.ncbi.nlm.nih.gov/pubmed/31640597
http://dx.doi.org/10.1186/s12883-019-1490-4

Ejemplares similares